Bradley Foster & Sargent’s Cytosorbents CTSO Stock Holding History
Bought
Maintained
Sold
Other funds holding CTSO
CM
Bradley Foster & Sargent's CTSO Position: Q4 2024 in Review
Bradley Foster & Sargent sold out of Cytosorbents (CTSO) in Q4 2024, closing a stake of 500 shares — an estimated $15K sold.
Bradley Foster & Sargent first reported a position in CTSO in Q2 2018 and held it in 25 quarters. The position peaked at $1.86M in Q3 2018. 50 funds tracked by Wall St. Rank hold CTSO as of Q4 2024.
- Bradley Foster & Sargent reported no remaining Cytosorbents position as of Q4 2024 after selling out during the quarter.
- Bradley Foster & Sargent sold 500 Cytosorbents shares in Q4 2024, an estimated $15K.
- Bradley Foster & Sargent first reported a position in Cytosorbents in Q2 2018 and held it in 25 quarters.
- Bradley Foster & Sargent's Cytosorbents position peaked at $1.86M in Q3 2018.
- 50 funds tracked by Wall St. Rank held Cytosorbents as of Q4 2024.
Based on Bradley Foster & Sargent's 13F filing for Q4 2024, filed 3 Feb 2025.